Unclaimed brand
For more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medicines that redefine the future for patients.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#FE2D2D
Red Orange
254, 45, 45
0, 99, 59
0, 82, 82, 0
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#333333
Mine Shaft
51, 51, 51
0, 0, 20
0, 0, 0, 80
Anthos Therapeutics is a clinical-stage biopharmaceutical company dedicated to accelerating the development of life-preserving therapies for patients at high risk of cardiovascular diseases. They specialize in the development and commercialization of genetically and pharmacologically validated innovative therapies for people living with cardiovascular and metabolic (CVM) diseases. Their mission is to combine the agility of a biotech with the rigor of a large pharmaceutical company to develop innovative therapies that advance care for those with cardiovascular and metabolic conditions.
Their most advanced program focuses on abelacimab, an investigational monoclonal antibody that targets Factor XI, a novel antithrombotic target. Abelacimab has the potential to provide 'hemostasis-sparing anticoagulation' by offering protection against thromboembolic events while reducing the risk of significant bleeding. Anthos Therapeutics was established by a world-class executive team with extensive experience in CVM therapies.
They obtained the global rights to develop and commercialize abelacimab under a license agreement with Novartis AG. Based in Cambridge, Massachusetts, Anthos Therapeutics follows a hybrid externalized model, combining their expertise with external partners to optimize drug development and manufacturing. Their commitment to scientific innovation and collaboration is evident through partnerships, industry collaborations, and participation in initiatives like Life Science Cares to address social issues.
Anthos Therapeutics is at the forefront of advancing healthcare by developing life-changing therapies to improve the lives of patients worldwide
